FDA Warns Of Bone Cement Complications In Vertebroplasty/Kyphoplasty
This article was originally published in The Gray Sheet
Executive Summary
FDA is formulating regulatory requirements for evaluating the safety and efficacy of bone cement products used in vertebroplasty and kyphoplasty procedures, the agency says in 1an Oct. 31 FDA public health web notification
You may also be interested in...
Spine Compression Fracture Treatments Compared By Cost, Leak Rate
The potential safety advantages of kyphoplasty over vertebroplasty and its ability to stave off additional spine repair procedures may outweigh its higher cost, according to speakers at the HealthPoint SPINE Summit in New York Oct. 9
Spine Compression Fracture Treatments Compared By Cost, Leak Rate
The potential safety advantages of kyphoplasty over vertebroplasty and its ability to stave off additional spine repair procedures may outweigh its higher cost, according to speakers at the HealthPoint SPINE Summit in New York Oct. 9
Regulatory News In Brief
HHS issues conflict of interest draft guidance: "1Financial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection" recommends taking measures such as separating responsibility for financial and research decisions and establishing CoI committees to verify the absence of financial interests. Aimed at individuals and organizations engaged in human subjects research, the March 31 guidance provides points to consider and aligns with December 2001 GAO recommendations calling on HHS to develop best practices for managing investigator and institutional financial CoI in biomedical research. Comments on the guidance are due by May 30...